Amgen (AMGN) Long-Term Debt Repayments (2009 - 2026)

Amgen has reported Long-Term Debt Repayments for 16 years, with the latest figure at $833.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Debt Repayments fell 66.68% year-over-year to $833.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 billion (down 45.36% YoY), and the FY2025 full-year result was $5.0 billion, up 38.89% from the prior year.
• Long-Term Debt Repayments for Q1 2026 stood at $833.0 million, down from $1.5 billion in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $2.5 billion in Q1 2025, with the low at $704.0 million in Q1 2023.
• Average Long-Term Debt Repayments over 4 years is $1.4 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Long-Term Debt Repayments soared 193.33% in 2024 and tumbled 66.68% in 2026.
• Tracing AMGN's Long-Term Debt Repayments over 4 years: stood at $750.0 million in 2023, then jumped by 193.33% to $2.2 billion in 2024, then sank by 31.82% to $1.5 billion in 2025, then tumbled by 44.47% to $833.0 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $833.0 million (Q1 2026), $1.5 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.

Peer Comparison